Hemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement Rx
NCT ID: NCT00666003
Last Updated: 2011-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2008-04-30
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy
NCT03078504
Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters
NCT01363505
Analysis of Clinical Outcomes in Patients Undergoing Acute Dialysis Therapy at Intensive Care Units
NCT01039753
Intensive Monitoring of Renal Function
NCT02657226
Hemodynamics in Chronic Kidney Disease
NCT06987032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Require dialysis
* CVP in place
* Use of Crit-Line and Flotrak device
Exclusion Criteria
* Use of an intra-aortic balloon pump
* Weight less than 90 lbs
* Cardiac arrhythmias
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baystate Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Baystate Medical Cetner
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Mailloux, D.O.
Role: PRINCIPAL_INVESTIGATOR
Baystate Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Baystate Medical Center
Springfield, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB07-120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.